These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19037622)
1. [Blindness after prostate biopsy]. Heinzelbecker J; von Zastrow C; Alken P Urologe A; 2009 Feb; 48(2):175-6. PubMed ID: 19037622 [TBL] [Abstract][Full Text] [Related]
2. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study. Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053 [TBL] [Abstract][Full Text] [Related]
3. Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases. Balaban M; Ozkaptan O; Sevinc C; Boz MY; Horuz R; Kafkasli A; Canguven O Int Braz J Urol; 2020; 46(1):60-66. PubMed ID: 31851459 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of duration of prophylactic antibiotics in transrectal ultrasound guided prostate biopsy. Bulut V; Şahin AF; Balaban Y; Altok M; Divrik RT; Zorlu F Int Braz J Urol; 2015; 41(5):906-10. PubMed ID: 26689515 [TBL] [Abstract][Full Text] [Related]
6. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Mosharafa AA; Torky MH; El Said WM; Meshref A Urology; 2011 Sep; 78(3):511-4. PubMed ID: 21782225 [TBL] [Abstract][Full Text] [Related]
7. [Prophylaxis of infectious complications following prostate biopsy]. Pilatz A; Lüdecke G; Wagenlehner F Urologe A; 2017 Jun; 56(6):759-763. PubMed ID: 28455575 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study. Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030 [TBL] [Abstract][Full Text] [Related]
15. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043 [TBL] [Abstract][Full Text] [Related]
16. Clostridia sepsis following transperineal needle biopsy of the prostate. Durkee CT J Urol; 1981 May; 125(5):752-3. PubMed ID: 6262540 [No Abstract] [Full Text] [Related]
17. Is the current antibiotic prophylaxis policy in transrectal prostate biopsy still safe? Thompson PM; Philpott-Howard J; Wang W BJU Int; 2009 Jul; 104(2):271-2. PubMed ID: 19594518 [No Abstract] [Full Text] [Related]
18. Editorial comment. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Hernandez-Graulau JM Urology; 2009 Aug; 74(2):338-9; author reply 339. PubMed ID: 19646618 [No Abstract] [Full Text] [Related]